Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease | Circulation
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
SciELO - Brasil - Doença de Kawasaki Doença de Kawasaki
Kawasaki Disease: A Review - Journal of Pediatric Health Care
Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018 - The Journal of Pediatrics
Kawasaki Disease
The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - International Journal of Cardiology
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years
Clinical and Experimental Pediatrics
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
Recurrence of Kawasaki Disease in a Young Child
Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997–2010: Effect of different case definitions in claims data analysis - ScienceDirect
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan | Archives of Disease in Childhood
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns | BMC Infectious Diseases | Full Text
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Frontiers | Antibodies and Immunity During Kawasaki Disease | Cardiovascular Medicine
Clinical Practice Guidelines : Kawasaki disease
Kawasaki's Disease
Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years
